Skip to content

Evaluation of SaCoVLM™ Video Laryngeal Mask for Airway Management in Military Medics

Evaluation of SaCoVLM™ Video Laryngeal Mask Airway for Airway Management by Inexperienced Military Medics: A Two-Phase Feasibility Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07249983
Acronym
SAVER
Enrollment
50
Registered
2025-11-25
Start date
2026-03-01
Completion date
2027-01-01
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Management, Tracheal Intubation, Anesthesia

Keywords

SaCoVLM™, Video Laryngeal Mask, Military Medic Training, Emergency Airway

Brief summary

A prospective, two-phase interventional study evaluating the performance, safety, and usability of the SaCoVLM™ video laryngeal mask airway for airway management by military medics with limited intubation experience. The study includes simulation-based training and clinical application in sedated patients undergoing elective surgery.

Detailed description

This prospective, two-phase study evaluates the use of the SaCoVLM™ video laryngeal mask airway by military medics with limited airway experience. Phase 1 involves simulated intubation on manikins to assess device placement, visualization quality, and intubation success. Phase 2 evaluates clinical performance in adult patients undergoing elective surgery under general anesthesia. Key outcomes include first-attempt success rates, insertion and intubation times, glottic visualization scores, and complication rates. The study aims to determine whether SaCoVLM™ can enable safe and effective airway management in resource-limited and prehospital military settings.

Interventions

Simulation-based and clinical use of SaCoVLM™ for airway management and intubation.

Sponsors

Charles University, Czech Republic
Lead SponsorOTHER
Military University Hospital, Prague
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Elective surgery * ASA I-II * need for airway management

Exclusion criteria

* Pregnancy * known airway abnormalities * allergy to anesthetics

Design outcomes

Primary

MeasureTime frameDescription
First-Attempt Success Rate of SaCoVLM™ InsertionWithin 10 minutes of airway intervention.Proportion of cases in which the SaCoVLM™ is successfully inserted on the first attempt during both simulated and clinical phases.
First-Attempt Success Rate of Orotracheal Intubation via SaCoVLM™Within 10 minutes following SaCoVLM™ placement.Proportion of successful orotracheal intubations on the first attempt using the SaCoVLM™ device as a conduit.

Secondary

MeasureTime frameDescription
Time to SaCoVLM™ InsertionDuring initial airway management (simulation or clinical setting).Time in seconds from picking up the device to successful confirmation of placement.
Time to Successful IntubationDuring initial airway management (simulation or clinical setting).Time in seconds from introduction of the endotracheal tube into the SaCoVLM™ to confirmed tracheal placement.
Glottic Visualization ScoreImmediately after SaCoVLM™ placement.Laryngeal view quality assessed using Keller-Brimacombe scale. The Keller-Brimacombe score ranges from Grade 1 (vocal cords not visible) to Grade 4 (only vocal cords visible with a full, unobstructed view), with higher grades indicating better glottic visualization and alignment for intubation.
Subjective Difficulty ScoreImmediately after each procedure.Operator-rated difficulty of device use on a 10-point visual analog scale (VAS).
Incidence of Airway ComplicationsFrom initiation of airway management to induction of general anesthesia (clinical phase only).Number of adverse airway events including hypoxemia (SpO₂ \< 90%), laryngospasm, or aspiration.

Countries

Czechia

Contacts

CONTACTJan Palenik, M.D.
jan.palenik@uvn.cz+420973203254
CONTACTJosef Klecatsky, M.D.
klecatsky.josef@uvn.cz+420973202999
PRINCIPAL_INVESTIGATORMichal Sotak, M.D., Ph.D.

Military University Hospital, Prague

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026